Literature DB >> 11453850

Simultaneous management of blood flow and IOP in glaucoma.

A Harris1, C Jonescu-Cuypers, B Martin, L Kagemann, M Zalish, H J Garzozi.   

Abstract

Factors other than intraocular pressure (IOP) elevation must be involved in initiation and progression of glaucoma. An additional element in disease causation may be ischemia in the retina and optic nerve head. Ischemic damage to neurons in the CNS is similar mechanistically and histopathologically to changes seen in glaucoma. Further, glaucoma patients with normal IOP show clear evidence for cerebral and ocular ischemia. Aging and atherosclerosis reduce the ability of the eye to autoregulate blood flow when ocular perfusion pressure changes: the dependence of blood flow on perfusion pressure links ischemia to IOP. Consequently, neuroprotective treatments for glaucoma should be designed to both reduce IOP and improve ocular nutrient delivery.

Entities:  

Mesh:

Year:  2001        PMID: 11453850     DOI: 10.1034/j.1600-0420.2001.079004336.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  10 in total

1.  Ophthalmology-Based Neuropathology Risk Factors: Diabetic Retinopathy is Associated with Deep Microinfarcts in a Community-Based Autopsy Study.

Authors:  Cecilia S Lee; Eric B Larson; Laura E Gibbons; Caitlin S Latimer; Shannon E Rose; Leanne L Hellstern; C Dirk Keene; Paul K Crane
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 2.  Ocular hemodynamics and glaucoma: the role of mathematical modeling.

Authors:  Alon Harris; Giovanna Guidoboni; Julia C Arciero; Annahita Amireskandari; Leslie A Tobe; Brent A Siesky
Journal:  Eur J Ophthalmol       Date:  2013 Mar-Apr       Impact factor: 2.597

Review 3.  Topical carbonic anhydrase inhibitors and glaucoma in 2021: where do we stand?

Authors:  Ari Stoner; Alon Harris; Francesco Oddone; Aditya Belamkar; Alice Chandra Verticchio Vercellin; Joshua Shin; Ingrida Januleviciene; Brent Siesky
Journal:  Br J Ophthalmol       Date:  2021-08-25       Impact factor: 5.908

4.  Update and critical appraisal of combined timolol and carbonic anhydrase inhibitors and the effect on ocular blood flow in glaucoma patients.

Authors:  Adam M Moss; Alon Harris; Brent Siesky; Deepam Rusia; Kathleen M Williamson; Yochai Shoshani
Journal:  Clin Ophthalmol       Date:  2010-04-26

5.  The effects of raloxifene hydrochloride on ocular hemodynamics and visual function.

Authors:  Brent Siesky; Alon Harris; Nisha Kheradiya; Rita Ehrlich; Carissa Klaas; Boaris Kaplan; Yara Catoira; Lynne McCranor; Carlos Rospigliosi; Mira Harris
Journal:  Int Ophthalmol       Date:  2008-04-22       Impact factor: 2.031

6.  Theoretical analysis of vascular regulatory mechanisms contributing to retinal blood flow autoregulation.

Authors:  Julia Arciero; Alon Harris; Brent Siesky; Annahita Amireskandari; Victoria Gershuny; Aaron Pickrell; Giovanna Guidoboni
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-08-19       Impact factor: 4.799

7.  Ocular blood flow as a clinical observation: Value, limitations and data analysis.

Authors:  Alon Harris; Giovanna Guidoboni; Brent Siesky; Sunu Mathew; Alice C Verticchio Vercellin; Lucas Rowe; Julia Arciero
Journal:  Prog Retin Eye Res       Date:  2020-01-24       Impact factor: 21.198

Review 8.  Caffeine and Its Neuroprotective Role in Ischemic Events: A Mechanism Dependent on Adenosine Receptors.

Authors:  R Brito; K C Calaza; D Pereira-Figueiredo; A A Nascimento; M C Cunha-Rodrigues
Journal:  Cell Mol Neurobiol       Date:  2021-03-17       Impact factor: 5.046

9.  Comparison of intraocular pressure, blood pressure, ocular perfusion pressure and blood flow fluctuations during dorzolamide versus timolol add-on therapy in prostaglandin analogue treated glaucoma subjects.

Authors:  Ingrida Januleviciene; Lina Siaudvytyte; Vaida Diliene; Ruta Barsauskaite; Daiva Paulaviciute-Baikstiene; Brent Siesky; Alon Harris
Journal:  Pharmaceuticals (Basel)       Date:  2012-03-21

10.  Blood Pressure and Heart Rate Variability to Detect Vascular Dysregulation in Glaucoma.

Authors:  Eva Charlotte Koch; Johanna Staab; Matthias Fuest; Katharina Witt; Andreas Voss; Niklas Plange
Journal:  J Ophthalmol       Date:  2015-10-01       Impact factor: 1.909

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.